Cigna Group (NYSE:CI) Stock Acquired Rep. Gilbert Ray Cisneros, Jr.

Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Cigna Group (NYSE:CI). In a filing disclosed on January 12th, the Representative disclosed that they had bought between $1,001 and $15,000 in Cigna Group stock on December 19th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Xiaomi (OTCMKTS:XIACF) on 12/30/2025.
• Sold $1,001 – $15,000 in shares of Schneider Electric S.E. (OTCMKTS:SBGSF) on 12/30/2025.
• Sold $1,001 – $15,000 in shares of Hermès International Société en commandite par actions (OTCMKTS:HESAF) on 12/30/2025.
• Purchased $50,001 – $100,000 in shares of Campbell’s (NASDAQ:CPB) on 12/30/2025.
• Sold $1,001 – $15,000 in shares of Tencent (OTC:TCTZF) on 12/30/2025.
• Sold $1,001 – $15,000 in shares of Mitsubishi Heavy Industries (OTCMKTS:MHVYF) on 12/26/2025.
• Sold $1,001 – $15,000 in shares of Bloom Energy (NYSE:BE) on 12/24/2025.
• Sold $1,001 – $15,000 in shares of Arista Networks (NYSE:ANET) on 12/24/2025.
• Sold $1,001 – $15,000 in shares of Coinbase Global (NASDAQ:COIN) on 12/24/2025.
• Sold $1,001 – $15,000 in shares of Chevron (NYSE:CVX) on 12/24/2025.

Cigna Group Stock Up 0.1%

Shares of NYSE CI opened at $272.03 on Thursday. The stock has a market cap of $72.67 billion, a P/E ratio of 12.00, a PEG ratio of 0.96 and a beta of 0.26. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74. Cigna Group has a 12-month low of $239.51 and a 12-month high of $350.00. The business’s fifty day simple moving average is $273.04 and its 200-day simple moving average is $287.88.

Cigna Group (NYSE:CI) last released its earnings results on Thursday, October 30th. The health services provider reported $7.83 EPS for the quarter, topping the consensus estimate of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.The firm had revenue of $69.57 billion during the quarter, compared to analysts’ expectations of $66.40 billion. During the same period in the previous year, the firm posted $7.51 EPS. Cigna Group’s revenue for the quarter was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities analysts predict that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th were given a dividend of $1.51 per share. The ex-dividend date of this dividend was Thursday, December 4th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio is currently 26.64%.

Insider Buying and Selling

In other Cigna Group news, CEO David Cordani purchased 4,134 shares of Cigna Group stock in a transaction that occurred on Monday, November 3rd. The stock was purchased at an average price of $241.88 per share, for a total transaction of $999,931.92. Following the transaction, the chief executive officer directly owned 157,935 shares in the company, valued at $38,201,317.80. This trade represents a 2.69% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.70% of the stock is currently owned by company insiders.

Analyst Ratings Changes

CI has been the subject of a number of recent research reports. Wolfe Research decreased their price target on shares of Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a research note on Wednesday, October 15th. Wells Fargo & Company reduced their price objective on shares of Cigna Group from $354.00 to $300.00 and set an “equal weight” rating on the stock in a report on Wednesday, November 5th. Mizuho set a $325.00 price objective on shares of Cigna Group in a research report on Friday, January 9th. Leerink Partners dropped their target price on Cigna Group from $300.00 to $270.00 in a report on Friday, October 31st. Finally, The Goldman Sachs Group cut their price target on Cigna Group from $370.00 to $330.00 and set a “buy” rating on the stock in a research note on Tuesday, November 4th. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $330.48.

Hedge Funds Weigh In On Cigna Group

Several large investors have recently bought and sold shares of CI. ORG Partners LLC increased its position in shares of Cigna Group by 3.3% during the fourth quarter. ORG Partners LLC now owns 1,959 shares of the health services provider’s stock worth $539,000 after purchasing an additional 62 shares in the last quarter. TrueMark Investments LLC increased its position in Cigna Group by 7.8% during the fourth quarter. TrueMark Investments LLC now owns 21,436 shares of the health services provider’s stock worth $5,900,000 after buying an additional 1,546 shares during the period. Thompson Investment Management Inc. lifted its stake in Cigna Group by 5.4% in the fourth quarter. Thompson Investment Management Inc. now owns 24,403 shares of the health services provider’s stock valued at $6,717,000 after buying an additional 1,251 shares during the last quarter. Goelzer Investment Management Inc. boosted its holdings in shares of Cigna Group by 1.6% in the fourth quarter. Goelzer Investment Management Inc. now owns 15,152 shares of the health services provider’s stock valued at $4,170,000 after acquiring an additional 232 shares during the period. Finally, Spire Wealth Management grew its position in shares of Cigna Group by 2.5% during the fourth quarter. Spire Wealth Management now owns 2,965 shares of the health services provider’s stock worth $816,000 after acquiring an additional 73 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.